Codi QR

Lessons From Immune Checkpoint Inhibitor Trials in Hepatocellular Carcinoma

The implementation of immune checkpoint inhibitors (ICI) into the clinical management of different malignancies has largely changed our understanding of cancer treatment. After having proven efficacy in different tumor entities such as malignant melanoma and lung cancer, ICI were intensively tested...

Descripció completa

Guardat en:
Autors principals: Raphael Mohr, Fabian Jost-Brinkmann, Burcin Özdirik, Joeri Lambrecht, Linda Hammerich, Sven H. Loosen, Tom Luedde, Münevver Demir, Frank Tacke, Christoph Roderburg
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2021-03-01
Col·lecció:Frontiers in Immunology
Matèries:
hepatocellular carcinoma
immunotherapy
checkpoint inhibitor treatment
clinical trials
liver cirrhosis
Accés en línia:https://www.frontiersin.org/articles/10.3389/fimmu.2021.652172/full
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars